Ocugen OCGN
NASDAQ OCGN
$0.96 +0.01 (+1.09%)
At close: Nov 11, 2026 · 4:00 PM EST

Ocugen (OCGN) Return on Capital Employed [ROCE] (2015 - 2026)

Updated

Ocugen (OCGN) posted Return on Capital Employed [ROCE] of -224.57% for Q1 2026, down 123.73 percentage points from -100.84% a year earlier but up 4.11 percentage points from the prior quarter.

Analysis

Ocugen (OCGN) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends

For FY2025, Ocugen's Return on Capital Employed [ROCE] came in at -157.54%, down 52.05 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -42.35 percentage points (FY2020 to FY2025).
  • In prior years, Ocugen's Return on Capital Employed [ROCE] was -105.49% in FY2024 (-11.20 pp), -94.29% in FY2023 (+18.94 pp), -113.23% in FY2022 (-15.81 pp) and -97.41% in FY2021 (+17.78 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -228.68% in Q4 2025 to a high of -41.44% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last three quarters, with an average year-over-year change of -29.32 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2021, with a gain of 79.31 percentage points; the weakest was Q1 2026, with a drop of 123.73 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -228.68% (Q4 2025), -169.61% (Q3 2025) and -134.97% (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Ocugen 322.34 Mn 87.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -224.57%
Dec 31, 2025 -228.68%
Sep 30, 2025 -169.61%
Jun 30, 2025 -134.97%
Mar 31, 2025 -100.84%
Dec 31, 2024 -108.21%
Sep 30, 2024 -147.82%
Jun 30, 2024 -183.08%
Mar 31, 2024 -141.76%
Dec 31, 2023 -124.75%
Sep 30, 2023 -124.57%
Jun 30, 2023 -132.14%
Mar 31, 2023 -116.07%
Dec 31, 2022 -106.16%
Sep 30, 2022 -81.39%
Jun 30, 2022 -55.93%
Mar 31, 2022 -63.38%
Dec 31, 2021 -55.78%
Sep 30, 2021 -41.44%
Jun 30, 2021 -55.41%
API Access

Ocugen Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OCGN&period=max&api_key=YOUR_API_KEY